IN

INVITES BIOCORE CO., LTD

A CRO advancing precision medicine via genomic analysis and clinical trial support services.

216400 | KO

Overview

Corporate Details

ISIN(s):
KR7216400002
LEI:
Country:
South Korea
Address:
서울특별시 금천구 디지털로9길 33, 금천구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Invites Biocore Co., Ltd. is a biotechnology company and Contract Research Organization (CRO) established in 2001. The company specializes in supporting new drug development and advancing precision medicine. Its core services include bioanalytical testing, central lab services, clinical trial support, and genetic and cell screening, with a focus on individual genomic analysis. By leveraging advanced technology, Invites Biocore partners with domestic and international pharmaceutical companies, research institutes, and medical institutions to facilitate personalized healthcare and support the data-based bio healthcare industry throughout the R&D lifecycle.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-04 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 91.6 KB
2025-06-17 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.6 KB
2025-06-10 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-05-21 00:00
Regulatory News Service
조회공시요구(풍문또는보도) (영업활동의 일부정지)
Korean 3.4 KB
2025-05-21 00:00
Regulatory News Service
주권매매거래정지 (풍문 또는 보도 관련)
Korean 5.0 KB
2025-05-21 00:00
Regulatory News Service
조회공시요구(풍문또는보도)에대한답변(부인)
Korean 5.4 KB
2025-05-21 00:00
Delisting Announcement
주권매매거래정지해제 (풍문 등 조회결과 공시)
Korean 4.3 KB
2025-04-30 00:00
Notice of Dividend Amount
[기재정정]현금ㆍ현물배당결정 (중간배당)
Korean 19.0 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 17.7 KB
2025-03-26 00:00
Board/Management Information
대표이사변경
Korean 10.1 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 15.5 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 2.1 MB
2025-03-13 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 200.7 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 8.7 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 170.3 KB

Automate Your Workflow. Get a real-time feed of all INVITES BIOCORE CO., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for INVITES BIOCORE CO., LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for INVITES BIOCORE CO., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

InterDigital, Inc. Logo
Develops and licenses essential wireless, video, and AI technologies for mobile devices and networks.
United States of America
IDCC
Interworks Confidence Inc. Logo
Specialized staffing and recruitment for the game, entertainment, and manufacturing sectors.
Japan
7374
INTLOOP Inc. Logo
Offers consulting, tech, and HR solutions leveraging a vast freelance professional network.
Japan
9556
IntoCell, Inc. Logo
Develops and licenses proprietary ADC platform technologies for cancer & immune therapies.
South Korea
287840
Intracom S.A. Holdings Logo
A multinational group delivering IT solutions, defense electronics, and construction projects.
Greece
INTRK
Inventionmed Spolka Akcyjna Logo
Develops VR medical simulators with haptic feedback for dermatology training.
Poland
INM
Inventiva Logo
Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.
France
IVA
IQVIA HOLDINGS INC. Logo
Global provider of analytics, tech, and clinical research for life sciences and healthcare.
United States of America
IQV
Isofol Medical Logo
Developing a drug to enhance chemotherapy efficacy for solid tumors like colorectal cancer.
Sweden
ISOFOL
B2B platform for Ukraine-Korea trade, investment, and post-war reconstruction.
South Korea
052770

Talk to a Data Expert

Have a question? We'll get back to you promptly.